With the worst of the credit crunch over and plenty of cheap candidates, General Electric (NYSE:GE) may be about to become more active with acquisitions. With some oblique comments from a senior executive, it would seem that this American conglomerate is once again about to leverage its considerable capital resources. Investors may want to consider the sorts of companies that GE may be looking at as potential targets.
Sticking to the Knitting
Although GE is a frequently-mentioned name in the guessing game of healthcare acquisitions, the company is actually rather focused and consistent with its healthcare business. GE is a significant presence in the imaging, diagnostics, life sciences and healthcare IT spaces. By and large, the company steers away from interventional products, so the likelihood that GE would buy a company like Stryker (NYSE:SYK) is quite low.
Cancer Therapy
Although GE is not active in interventional medicine, Varian (NYSE:VAR) might be a logical way for the company to make that transition. An argument could be made that Varian's radiation therapy systems would be a natural extension of GE's diagnostic imaging products. Along similar lines, TomoTherapy (Nasdaq:TOMO) or Accuray (Nasdaq:ARAY) could get some consideration, though TOMO may be too small and Accuray too novel.
The link below will take you to the full article:
http://stocks.investopedia.com/stock-analysis/2010/Is-GE-About-To-Stir-Up-The-Medical-Arena-GE-VAR-VOLC-MASI-BRKR-TMO-ISRG1019.aspx
Showing posts with label acquisition. Show all posts
Showing posts with label acquisition. Show all posts
Tuesday, October 19, 2010
Is GE About To Stir Up The Medical Arena?
Labels:
Accuray,
acquisition,
Bruker,
buyout,
Covidien,
GE,
GE Healthcare,
Hologic,
Intuitive Surgical,
Masimo,
Philips,
Qiagen,
Siemens,
Stryker,
Thermo Fisher,
Tomotherapy,
Varian,
Volcano
Monday, October 4, 2010
Actel - A Logical Deal For Microsemi
Microsemi (Nasdaq: MSCC) has definitely been on an acquisition binge here of late, and now the company is adding Actel (Nasdaq: ACTL) to the stable. Microsemi announced this morning that it was buying Actel in an all-cash deal; offering $20.88 a share. That is not too bad of a premium to pay for MSCC shareholders like me, and the $430 million net cash price will be covered in part by term loan facility and revolver from Morgan Stanley.
Actel specializes in low-power FPGAs and there should be some definite synergies with Microsemi's existing business. In particular, Actel's radiation-tolerant chips should fit in nicely with Microsemi's communications, space, and satellite businesses. Moreover, because Actel is relatively specialized and focused, I do not think Microsemi needs to worry about now competing with Altera (Nasdaq: ALTR) or Xilinx (Nasdaq: XLNX) - two much larger competitors in the overall FPGA segment of the semiconductor market.
Actel was, and is, a largely unknown semiconductor company. It is a small company (note the $430M net price) with effectively no analyst coverage. Nevertheless, the company has been reporting some better quarters of late and seems to have some momentum in the business ... but results have been a little erratic historically. Sales have grown pretty consistently over the past decade, but operating margins have been all over the place (not unusual for semiconductor companies, especially the smaller ones).
All in all, it looks like a good (and logical) deal for Microsemi. I'm a little surprised when companies start showing bursts of acquisition activity, but so far MSCC's deals have made sense and this Actel acquisition should be pretty accretive for the company, and relatively soon at that. Over the longer term, this should deepen (and broaden) MSCC's existing business relationships and may open the door to some new product/market opportunities for the company.
I suppose Actel shareholders might be annoyed at the relatively modest premium for their shares, but that is what happens when a company flies below the radar. If nothing else, maybe Actel shareholders should think about taking the cash from Microsemi and reinvesting it in Microsemi shares - the company is doing well, the business is an intriguing combination of "niche" and "growth", and the stock should still have some room to run.
Oh, by the way ... Lattice Semiconductor (Nasdaq: LSCC) is eerily similar to Actel in a lot of respects (an FPGA company, similar market cap, etc.). I'm not predicting a buyout here, but for anybody looking for "the next Actel", the similarities are there...
Disclosure - I own shares of Microsemi.
Actel specializes in low-power FPGAs and there should be some definite synergies with Microsemi's existing business. In particular, Actel's radiation-tolerant chips should fit in nicely with Microsemi's communications, space, and satellite businesses. Moreover, because Actel is relatively specialized and focused, I do not think Microsemi needs to worry about now competing with Altera (Nasdaq: ALTR) or Xilinx (Nasdaq: XLNX) - two much larger competitors in the overall FPGA segment of the semiconductor market.
Actel was, and is, a largely unknown semiconductor company. It is a small company (note the $430M net price) with effectively no analyst coverage. Nevertheless, the company has been reporting some better quarters of late and seems to have some momentum in the business ... but results have been a little erratic historically. Sales have grown pretty consistently over the past decade, but operating margins have been all over the place (not unusual for semiconductor companies, especially the smaller ones).
All in all, it looks like a good (and logical) deal for Microsemi. I'm a little surprised when companies start showing bursts of acquisition activity, but so far MSCC's deals have made sense and this Actel acquisition should be pretty accretive for the company, and relatively soon at that. Over the longer term, this should deepen (and broaden) MSCC's existing business relationships and may open the door to some new product/market opportunities for the company.
I suppose Actel shareholders might be annoyed at the relatively modest premium for their shares, but that is what happens when a company flies below the radar. If nothing else, maybe Actel shareholders should think about taking the cash from Microsemi and reinvesting it in Microsemi shares - the company is doing well, the business is an intriguing combination of "niche" and "growth", and the stock should still have some room to run.
Oh, by the way ... Lattice Semiconductor (Nasdaq: LSCC) is eerily similar to Actel in a lot of respects (an FPGA company, similar market cap, etc.). I'm not predicting a buyout here, but for anybody looking for "the next Actel", the similarities are there...
Disclosure - I own shares of Microsemi.
Labels:
acquisition,
Actel,
Altera,
FPGA,
Lattice Semiconductor,
Microsemi,
Morgan Stanley,
Xilinx
Wednesday, June 23, 2010
A Little More On Santander And M&T Bank
Just a quick little follow-up on the rumor of a get-together between Spain's Santander (NYSE: SAN) and super-regional M&T Bank (NYSE: MTB).
There was news a couple of days ago that Santander was looking to restart talks with M&T management about the possibility of a deal. If the news reports are accurate, the problem is pretty fundamental - M&T does not want to sell and/or give up control to Santander. Given the history of the M&T, the long tenure of senior management, the significant employee ownership, and the whole culture of the bank (as best an outsider like myself can sense), this is not really a surprise.
In other words, Santander is probably welcome to buy Allied Irish Bank's (NYSE: AIB) stake in M&T, but Santander will be expected to operate under similar strictures as AIB - namely, can you offer some suggestions and we won't dilute your interests, but we're not interested in being your subsidiary.
If Santander pushes the matter, they likely will fail. About 20% of M&T is owned by employees, another 5% by Berkshire Hathaway (NYSE: BRK-A), and the 22% or so held by AIB. Assuming AIB has the option to side with M&T management, it is pretty much a non-starter for Santander, and I have to imagine that AIB has other options to monetize their stake if they really wish to pursue them (in other words, I don't think AIB turns over on M&T to make a buck).
I still think Santander is a decent suitor at the right price; I don't think they will ruin M&T and I think there's a fair chance that they would put M&T at the head of their US operations (maybe to the detriment of US-based, Santander-owned Sovereign Bancorp). All in all, Santander is a very good bank and while it may not have quite the same culture as M&T, Santander's relative conservatism has helped them muddle through this credit crisis better than most.
What if the deal doesn't happen? M&T will pretty much continue on as before, growing at a modest organic pace and perhaps considering strategic deals here and there. Santander, though, is not likely to quit. Whether they would look to go large (say, Suntrust (NYSE: STI) or PNC (NYSE: PNC)) or more moderate (deals the size of Fifth Third (Nasdaq: FITB) or Comerica (NYSE: CMA), for instance), I don't think Santander is done building its U.S. business just yet.
There was news a couple of days ago that Santander was looking to restart talks with M&T management about the possibility of a deal. If the news reports are accurate, the problem is pretty fundamental - M&T does not want to sell and/or give up control to Santander. Given the history of the M&T, the long tenure of senior management, the significant employee ownership, and the whole culture of the bank (as best an outsider like myself can sense), this is not really a surprise.
In other words, Santander is probably welcome to buy Allied Irish Bank's (NYSE: AIB) stake in M&T, but Santander will be expected to operate under similar strictures as AIB - namely, can you offer some suggestions and we won't dilute your interests, but we're not interested in being your subsidiary.
If Santander pushes the matter, they likely will fail. About 20% of M&T is owned by employees, another 5% by Berkshire Hathaway (NYSE: BRK-A), and the 22% or so held by AIB. Assuming AIB has the option to side with M&T management, it is pretty much a non-starter for Santander, and I have to imagine that AIB has other options to monetize their stake if they really wish to pursue them (in other words, I don't think AIB turns over on M&T to make a buck).
I still think Santander is a decent suitor at the right price; I don't think they will ruin M&T and I think there's a fair chance that they would put M&T at the head of their US operations (maybe to the detriment of US-based, Santander-owned Sovereign Bancorp). All in all, Santander is a very good bank and while it may not have quite the same culture as M&T, Santander's relative conservatism has helped them muddle through this credit crisis better than most.
What if the deal doesn't happen? M&T will pretty much continue on as before, growing at a modest organic pace and perhaps considering strategic deals here and there. Santander, though, is not likely to quit. Whether they would look to go large (say, Suntrust (NYSE: STI) or PNC (NYSE: PNC)) or more moderate (deals the size of Fifth Third (Nasdaq: FITB) or Comerica (NYSE: CMA), for instance), I don't think Santander is done building its U.S. business just yet.
Labels:
acquisition,
Allied Irish Bank,
Berkshire Hathaway,
Comerica,
Fifth Third,
merger,
MT Bank,
MTB,
PNC,
Santander,
Suntrust
Thursday, June 17, 2010
M&T and Santander ... This Could Actually Make Sense
Rumor going around is that Spanish banking giant Santander (NYSE: STD) may consider a bid for the exceptionally well-run M&T Bank (NYSE: MTB). If this happens to be true, it is a deal I would probably like ... at the right price, of course.
For those not familiar with it, MTB is a Buffalo-based bank with operations across the Mid-Atlantic. While the return on equity and return on assets do not immediately jump out as top-tier, it is widely considered one of the best-run banks in the country. I happen to share that opinion, and would group it along with the likes of US Bancorp (NYSE: USB) and BB&T (NYSE: BBT) as some of the best-run banks in the country. As such, they have not been hurt quite so badly by the housing/credit boom and bust.
What makes this an intriguing deal is that Santander is also an exceptionally well-run bank, even if it carries the "Scarlet S" of being a Spanish bank. Santander gets about 25% of its profits from Spain, with 21% coming from Brazil, 14% from "other" Latin American countries, 12% from the UK, but only a tiny bit (about 2%) from its US business (from its acquisition of Sovereign a few years back). Although the U.S. is not an under-banked market by any means, it is a profitable one and it is reasonable to think STD would have interest.
The opening for Santander is coming, ironically enough, from problems at another large European bank. MTB is 25%-owned by Allied Irish Banks (NYSE: AIB), a good-enough bank when times were good in Ireland. Times are not nearly so good now, though, and AIB is under pressure to raise capital. With MTB shares near a 52-week high, selling that stake could be a very appealing means of generating that needed capital.
Ahhh, but now for the "but". In this case, the "but" is valuation. Even if I stretch some of my assumptions about future growth, I have a tough time going above $100 per share in fair value. Given the restrictions on moving deposits across borders (collecting deposits in Buffalo to fund loans in Buenos Aires is frowned upon), there would not be a lot of synergies for Santander. So, the question for me is whether Santander can basically position AIB over the barrel and strike a bargain price on the stake (as large blocks of stock often move at discounts, similar to public share offerings), and use some of that to offset the takeover premium it will have to pay to buy a controlling stake.
Then again, that assumes that Santander wants, or feels it needs, full control. They could, conceivably be content with just holding that sizable stake and cashing dividend checks.
Personally, I don't think this deal happens I'm coming around to the idea that this deal eventually gets done. It makes sense, but I'm not sure Santander is in a position to do anything quite so bold, and I'm not sure AIB wants to let go of its MTB stake if it has other options to avoid it. Still, should the deal happen, it has the advantage of being a combination of two very well-run banks. As it stands now, Santander is a stock that is definitely on my watch list whether the deal happens or not.
I wrote that prior paragraph last night, and after sleeping on it, I'm changing my mind. I think the odds of a deal are at least 50-50. Santander has a lot of pressures at home and the capital stress tests going on in Europe now might limit just how bold Santander can be. Nevertheless, AIB will have almost no choice but to sell its stake and Santander is clearly interested in expanding its U.S. footprint. If the deal happens, it's a marriage of two very well-run banks. But even if the deal does not go off, I would be happy owning either bank. As it stands now, Santander looks cheap and it is definitely on my watch list.
Full disclosure - I own share of BBT
In the original posting I forgot to mention that M&T and Santander have talked before about a merger. I apologize for not mentioning that as it certainly ups the odds of a transaction.
For those not familiar with it, MTB is a Buffalo-based bank with operations across the Mid-Atlantic. While the return on equity and return on assets do not immediately jump out as top-tier, it is widely considered one of the best-run banks in the country. I happen to share that opinion, and would group it along with the likes of US Bancorp (NYSE: USB) and BB&T (NYSE: BBT) as some of the best-run banks in the country. As such, they have not been hurt quite so badly by the housing/credit boom and bust.
What makes this an intriguing deal is that Santander is also an exceptionally well-run bank, even if it carries the "Scarlet S" of being a Spanish bank. Santander gets about 25% of its profits from Spain, with 21% coming from Brazil, 14% from "other" Latin American countries, 12% from the UK, but only a tiny bit (about 2%) from its US business (from its acquisition of Sovereign a few years back). Although the U.S. is not an under-banked market by any means, it is a profitable one and it is reasonable to think STD would have interest.
The opening for Santander is coming, ironically enough, from problems at another large European bank. MTB is 25%-owned by Allied Irish Banks (NYSE: AIB), a good-enough bank when times were good in Ireland. Times are not nearly so good now, though, and AIB is under pressure to raise capital. With MTB shares near a 52-week high, selling that stake could be a very appealing means of generating that needed capital.
Ahhh, but now for the "but". In this case, the "but" is valuation. Even if I stretch some of my assumptions about future growth, I have a tough time going above $100 per share in fair value. Given the restrictions on moving deposits across borders (collecting deposits in Buffalo to fund loans in Buenos Aires is frowned upon), there would not be a lot of synergies for Santander. So, the question for me is whether Santander can basically position AIB over the barrel and strike a bargain price on the stake (as large blocks of stock often move at discounts, similar to public share offerings), and use some of that to offset the takeover premium it will have to pay to buy a controlling stake.
Then again, that assumes that Santander wants, or feels it needs, full control. They could, conceivably be content with just holding that sizable stake and cashing dividend checks.
I wrote that prior paragraph last night, and after sleeping on it, I'm changing my mind. I think the odds of a deal are at least 50-50. Santander has a lot of pressures at home and the capital stress tests going on in Europe now might limit just how bold Santander can be. Nevertheless, AIB will have almost no choice but to sell its stake and Santander is clearly interested in expanding its U.S. footprint. If the deal happens, it's a marriage of two very well-run banks. But even if the deal does not go off, I would be happy owning either bank. As it stands now, Santander looks cheap and it is definitely on my watch list.
Full disclosure - I own share of BBT
In the original posting I forgot to mention that M&T and Santander have talked before about a merger. I apologize for not mentioning that as it certainly ups the odds of a transaction.
Labels:
acquisition,
AIB,
banking,
BBT,
MTB,
Santander,
Sovereign Bank,
STD,
USB
Subscribe to:
Posts (Atom)